Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • News & Views
  • Published:

Rheumatoid arthritis

Why wait? Explaining delays in seeking therapy for early arthritis

Early diagnosis and treatment of rheumatoid arthritis improves long-term outcomes and reduces or halts joint damage progression. However, delays at the patient and medical system levels remain a barrier to early diagnosis and therapy, despite the presence of early arthritis clinics designed to expedite treatment.

This is a preview of subscription content, access via your institution

Relevant articles

Open Access articles citing this article.

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. McInnes, I. B. & O'Dell, J. R. State-of-the-art: rheumatoid arthritis. Ann. Rheum. Dis. 69, 1898–1906 (2010).

    Article  CAS  Google Scholar 

  2. Hazesm J. M. & Luime, J. J. The epidemiology of early inflammatory arthritis. Nature Rev. Rheumatol. 7, 381–390 (2011).

    Article  Google Scholar 

  3. Goëb, V., Smolen, J., Emery, P. & Marzo-Ortega, H. Early inflammatory clinics. Experience with early arthritis/back pain clinics. Clin. Exp. Rheumatol. 27 (Suppl. 55), S74–S79 (2009).

    PubMed  Google Scholar 

  4. Stack, R. J. et al. Delays in help seeking at the onset of the symptoms of rheumatoid arthritis: a systematic synthesis of qualitative literature. Ann. Rheum. Dis. http://dx.doi.org/10.1136/ard.2011.155416.

  5. Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum. 62, 2569–2581 (2010).

    Article  Google Scholar 

  6. Aletaha, D. et al. 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Ann. Rheum. Dis. 69, 1580–1588 (2010).

    Article  Google Scholar 

  7. Smolen, J. S. et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann. Rheum. Dis. 69, 964–975 (2010).

    Article  CAS  Google Scholar 

  8. van der Linden, M. P., Knevel, R., Huizinga, T. W. & van der Helm-van Mil, A. H. Classification of rheumatoid arthritis: comparison of the 1987 American College of Rheumatology criteria and the 2010 American College of Rheumatology/European League Against Rheumatism criteria. Arthritis Rheum. 63, 37–42 (2011).

    Article  CAS  Google Scholar 

  9. van Venrooij, W. J., van Beers, J. J. & Pruijn, G. J. Anti-CCP antibodies: the past, the present and the future. Nat. Rev. Rheumatol. 7, 91–98 (2011).

    Article  Google Scholar 

  10. Olivieri, I. et al. Early treatment in early undifferentiated arthritis. Autoimmun. Rev. http://dx.doi.org/10.1016/j.autrev.2011.10.019

Download references

Acknowledgements

We wish to acknowledge Dr Kevin Smart for language support ahead of submission.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Piercarlo Sarzi-Puttini.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Atzeni, F., Sarzi-Puttini, P. Why wait? Explaining delays in seeking therapy for early arthritis. Nat Rev Rheumatol 8, 190–191 (2012). https://doi.org/10.1038/nrrheum.2012.24

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nrrheum.2012.24

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing